Live Webinar and Q&A
Methods to Reliably Monitor Regulatory T Cells in Clinical Studies: Characterizing a Central Switch of Immune Suppression
Wednesday, October 12, 2022
11:00 AM ET | 5:00 PM CET
(Duration: 50 Minutes)
Regulatory T (Treg) cells are a crucial cell type of immune suppression and relevant in a wide range of disease indications. Reliable monitoring in clinical trials has challenges and different technology solutions have been developed including flow cytometry as well as epigenetic immune monitoring (Epiontis ID).
In this webinar we will outline the discovery of Treg cells and their role in the immune system. Using several case studies in autoimmune disease, cancer and a Treg-related rare disease called IPEX we will present established solutions that allow reliable monitoring of Treg cells in blood and tissue samples in clinical trials.
Read below for more details, challenges addressed, and featured speakers.
Key points covered:
-
Discovery of Tregs and the major role of Treg cells in the immune system
-
Historic challenges in monitoring Tregs
- Optimized methods for monitoring Treg cells using a wide range of sample types including blood and tissue
- Case studies of Treg monitoring in autoimmune disease and cancer
About our Speakers
Uli Hoffmueller, PhD
Vice President, Immune Monitoring Solutions
Dr. Hoffmueller is a subject matter expert for immune monitoring solutions at Precision for Medicine, advising clients on ideal approaches for their specific clinical study needs. In 2003 he co-founded Epiontis, which was acquired by Precision for Medicine in 2017. He received his Ph.D. from the Institute of Medical Immunology of the Charité University Clinic, Berlin.
Eva Raschke, PhD
Director, Scientific Affairs
Dr. Raschke serves as a subject matter expert for immune monitoring solutions at Precision for Medicine with a focus on the epigenetic immune monitoring technology Epiontis ID. She has supported the development, validation and clinical use of this technology platform in different roles since 2008. Eva obtained a Ph.D. in Molecular Biology from the Ludwig-Maximilians-University Munich.
©2024 Precision for Medicine. All rights reserved. Privacy Policy